Parexel swoops in to hire ex-GSK researchers; BBK teams up with ACRES;

> As GlaxoSmithKline ($GSK) prepares to cut hundreds of jobs in North Carolina, partner Parexel International ($PRXL) has promised to offer positions to about 450 of the affected workers. News

> Patient-recruitment specialist BBK Worldwide has partnered up with the nonprofit Alliance for Clinical Research Excellence and Safety to help the organization in accrediting clinical trial sites. More

> Catalent ($CTLT) has signed on with Concord, MA-based Valerion Therapeutics to help develop delivery technology for the company's line of orphan genetic treatments. Story

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.